Lung recurrence and its therapeutic strategy in patients with pancreatic cancer
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 20 (1) , 89-94
Abstract
No abstract availableKeywords
Funding Information
- Grants-in-Aid for Scientific Research (18K08626)
- Japan Society for the Promotion of Science
- Ministry of Health, Labour and Welfare, Japan
This publication has 24 references indexed in Scilit:
- Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal AdenocarcinomaDigestive Surgery, 2015
- Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patternsOncotarget, 2015
- Warranting Investigation of Primary Lung Adenocarcinoma in Patients With an Extrapulmonary Malignancy and Lung Nodules Due to High FrequencyAmerican Journal of Clinical Pathology, 2014
- KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomasLaboratory Investigation, 2014
- Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?World Journal of Gastroenterology, 2012
- Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and SurvivalJournal of Gastrointestinal Surgery, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor GenesScience, 2010
- Prognostic factors in 1038 women with metastatic breast cancerAnnals of Oncology, 2008
- Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parametersEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006